Colin Kunzweiler
Director - Infectious Disease Epidemiology Moderna
Colin Kunzweiler, PhD, is an infectious disease epidemiologist with professional experience in state health departments, RWE/HEOR consulting, and pharmaceutical industry. Dr. Kunzweiler currently is a Director of Infectious Disease Epidemiology at Moderna, Inc. where he advances RWE strategy across vaccine development. Dr. Kunzweiler’s observational/non-interventional study portfolio leverages diverse real-world data sources and methodologies to better inform regulatory and lifecycle decision-making.
Seminars
Thursday 29th October 2026
Accelerating Decisions with Epidemiology When Uncertainty Limits Development Confidence
11:30 am
- Identifying the right patient populations and geographies early to reduce uncertainty and enable faster, more confident clinical trial decisions
- Exploring how epidemiology and real-world evidence can support expansion beyond initial indications to unlock broader patient access and long term value
- Helping leadership make confident investment decisions by translating epidemiological insight into clear, decision‑relevant evidence that reduces risk and accelerates alignment
